Analystreport

Editas Medicine, Inc. (NASDAQ: EDIT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com